Menu

rss
Evid Based Nurs 6:76 doi:10.1136/ebn.6.3.76
  • Treatment

Review: regular inhaled long acting β2 agonists are associated with better outcomes than short acting β2 agonists in adults and children with chronic asthma

(2002) Cochrane Database Syst Rev 4, CD003901; Walters EH, Walters JA, Gibson PW.. Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma.. ;(. ):. (latest version 24 Apr 2002).


 
 QUESTION: What is the effectiveness of regular inhaled long acting β2 agonists compared with inhaled short acting β2 agonists in adults and children with chronic asthma?

Data sources

Studies were identified using the Cochrane Airways Review Group register, which is derived from searching Medline, CINAHL, and EMBASE/Excerpta Medica. In addition, bibliographies of relevant studies were scanned, key respiratory care journals were hand searched, and experts were contacted.

Study selection

Randomised controlled trials of ≥2 weeks duration were selected if they compared a regular inhaled long acting β2 agonist with a regular inhaled short acting β2 agonist of equivalent (as far as possible) bronchodilator effectiveness in adults or children with chronic asthma (ie, those with a diagnosis of ≥6 mo). Studies including participants with other pulmonary …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

EBN Twitter Journal Club

The club runs like other journal discussion groups, except that the article and questions are posted on this blog and the discussion about the article happens on Twitter.

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.